The US government has been raking in False Claims Act settlements and judgments in recent years, with the 2022 tally reaching $1.7bn for the health care industry alone. And those numbers seem likely to only grow in the future. Many of those settlements are the result of qui tam, or whistleblower, suits, in which an individual – often a former employee – files a complaint on behalf of the government.
At December’s Food and Drug Law Institute Enforcement, Litigation and Compliance Conference in Washington, DC, a panel of attorneys discussed...
